Figure 4From: Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand Probabilistic sensitivity analysis. For probabilistic sensitivity analysis in the base case (i.e., general population aged 18 years old, acceptance rate of 80%, and unchanged risk behaviors), these graphs demonstrate the probabilities of the HIV vaccine cost for each duration of protection and each vaccine efficacy level of (A) 30%, (B) 50%, and (C) 70% being cost-effective at the WTP threshold of 100,000 THB per QALY gained. ICER: incremental cost-effectiveness ratio; THB: Thai baht as of 2009 value; and QALY: quality adjusted life year.Back to article page